Growth Metrics

Alnylam Pharmaceuticals (ALNY) Non-cash Items (2017 - 2018)

Alnylam Pharmaceuticals (ALNY) has disclosed Non-cash Items for 8 consecutive years, with $1.4 million as the latest value for Q4 2018.

  • For Q4 2018, Non-cash Items fell 98.85% year-over-year to $1.4 million; the TTM value through Dec 2018 reached $1.4 million, down 98.85%, while the annual FY2018 figure was $1.4 million, 98.85% down from the prior year.
  • Non-cash Items hit $1.4 million in Q4 2018 for Alnylam Pharmaceuticals, down from $123.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $123.8 million in Q4 2017 and bottomed at $1.4 million in Q4 2018.
  • Average Non-cash Items over 4 years is $36.5 million, with a median of $10.5 million recorded in 2014.
  • Year-over-year, Non-cash Items surged 242.99% in 2015 and then plummeted 98.85% in 2018.
  • Alnylam Pharmaceuticals' Non-cash Items stood at $4.7 million in 2014, then soared by 242.99% to $16.2 million in 2015, then skyrocketed by 662.1% to $123.8 million in 2017, then tumbled by 98.85% to $1.4 million in 2018.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $1.4 million, $123.8 million, and $16.2 million for Q4 2018, Q4 2017, and Q4 2015 respectively.